Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Rheumatoid arthritis? 152 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Rheumatoid arthritis have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 11.0% of all adverse event reports for LEVOMILNACIPRAN.

152
Reports of Rheumatoid arthritis with LEVOMILNACIPRAN
11.0%
of all LEVOMILNACIPRAN reports
150
Deaths
100
Hospitalizations

How Dangerous Is Rheumatoid arthritis From LEVOMILNACIPRAN?

Of the 152 reports, 150 (98.7%) resulted in death, 100 (65.8%) required hospitalization, and 100 (65.8%) were considered life-threatening.

Is Rheumatoid arthritis Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Abdominal pain upper (285) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276)

What Other Drugs Cause Rheumatoid arthritis?

ETANERCEPT (33,166) ADALIMUMAB (29,817) METHOTREXATE (29,254) ABATACEPT (21,898) LEFLUNOMIDE (20,886) TOCILIZUMAB (20,652) HYDROXYCHLOROQUINE (20,110) RITUXIMAB (19,850) CERTOLIZUMAB PEGOL (17,782) INFLIXIMAB (16,251)

Which LEVOMILNACIPRAN Alternatives Have Lower Rheumatoid arthritis Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Rheumatoid arthritis Reports All Drugs Causing Rheumatoid arthritis LEVOMILNACIPRAN Demographics